1. Home
  2. PWP vs BBNX Comparison

PWP vs BBNX Comparison

Compare PWP & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$14.50

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$21.52

Market Cap

997.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PWP
BBNX
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
997.9M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
PWP
BBNX
Price
$14.50
$21.52
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
$23.50
★ $23.80
AVG Volume (30 Days)
1.2M
★ 1.3M
Earning Date
05-01-2026
04-21-2026
Dividend Yield
★ 1.31%
N/A
EPS Growth
★ 138.52
78.95
EPS
★ 0.08
N/A
Revenue
N/A
★ $100,251,000.00
Revenue This Year
$28.86
$34.90
Revenue Next Year
$18.95
$34.63
P/E Ratio
$172.38
★ N/A
Revenue Growth
N/A
★ 53.94
52 Week Low
$12.52
$8.80
52 Week High
$25.93
$32.71

Technical Indicators

Market Signals
Indicator
PWP
BBNX
Relative Strength Index (RSI) 46.01 59.87
Support Level $12.52 $12.45
Resistance Level $17.51 $32.42
Average True Range (ATR) 0.88 1.68
MACD -0.02 0.19
Stochastic Oscillator 43.56 75.40

Price Performance

Historical Comparison
PWP
BBNX

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: